PP
KITE

PDT Partners’s Kite Pharma, Inc. KITE Stock Holding History

PDT Partners’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-6,260
Closed -$349K – 1192
2015
Q3 		$349K Sell
6,260
-10,833
-63% -$681K 0.01% 1012
2015
Q2 		$1.04M Buy
+17,093
New +$975K 0.03% 731

Other funds holding KITE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WCM
Wildcat Capital Management New York $106M AUM 0.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

PDT Partners's KITE Position: Q4 2015 in Review

PDT Partners sold out of Kite Pharma, Inc. (KITE) in Q4 2015, closing a stake of 6,260 shares — an estimated $349K sold.

PDT Partners first reported a position in KITE in Q2 2015 and held it in 2 quarters. The position peaked at $1.04M in Q2 2015. 187 funds tracked by Wall St. Rank hold KITE as of Q4 2015.

  • PDT Partners reported no remaining Kite Pharma, Inc. position as of Q4 2015 after selling out during the quarter.
  • PDT Partners sold 6,260 Kite Pharma, Inc. shares in Q4 2015, an estimated $349K.
  • PDT Partners first reported a position in Kite Pharma, Inc. in Q2 2015 and held it in 2 quarters.
  • PDT Partners's Kite Pharma, Inc. position peaked at $1.04M in Q2 2015.
  • 187 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2015.

Based on PDT Partners's 13F filing for Q4 2015, filed 16 Feb 2016.